Key Highlights

  • Terragen (ASX:TGH) shares traded at $0.012, down 14.29%, during the 26 October 2026 session.
  • Revenue from ordinary operations fell 11.3% to $1.43m.
  • The loss attributable to members was $3.75m.

Terragen Holdings Ltd (ASX:TGH) shares traded at $0.012, down 14.29%, during the Trading session on 26 October 2026, while the S&P/ASX 200 index (XJO) stood at 8,805.30, up 0.11% or 10.10 points, at 2:06 pm. Separately, the company's latest announcement on file is dated FY26 Appendix 4E and covers its Appendix 4E preliminary final report for the year ended 30 June 2026.

Terragen Holdings supplies microbial products for agriculture, and the report sets out revenue, loss and cash for FY26. The release is dated earlier than the session, so the share price movement and the announcement are reported as separate items.

FY26 results (year ended 30 June 2026)

Revenue was $1,432,082 compared with $1,615,253, a fall of 11.3%, mainly from sales of Mylo, Terragen Probiotic for Ruminants and Great Land Plus. The loss attributable to members was $3,751,367 against $3,723,830, up 0.7%. Net tangible assets per share were 1.06 cents against 1.13 cents, and no Dividend was declared.

Financial position

Cash and cash equivalents were $7,253,956 against $4,701,017 a year earlier, with Gross Profit of $849,123 and other income of $799,259. The report discloses risks including Manufacturing and product quality, and the company did not gain or lose control of any entities.

About Terragen

Terragen Holdings Limited (ASX:TGH) develops and supplies microbial and biological products for agriculture and animal health, including products used in ruminant and soil applications.

Related sector context

Agricultural biologicals suppliers rely on seasonal Demand and customer adoption, and quality control in manufacturing is a recurring operational risk noted in the report.

The XJO was up 0.11% at 2:06 pm on the day.

Risks to weigh in

Revenue declined and the loss was near the prior year, and the report notes the need for profitability to cover ongoing costs. Shares priced at $0.012 can move sharply in either direction.

Catalysts on watch

Items to follow include the annual report, sales trends for key products and the quarterly Cash Flow report.

Bringing it together

Terragen (ASX:TGH) traded 14.29% lower during the 26 October 2026 session, while its latest release, dated FY26 Appendix 4E, reported lower FY26 Revenue and a loss of $3.75 million.